Abstract
Variant interpretation remains a major challenge in medical genetics. We developed Meta-Domain HotSpot (MDHS) to identify mutational hotspots across homologous protein domains. We applied MDHS to a dataset of 45,221 de novo mutations (DNMs) from 31,058 patients with neurodevelopmental disorders (NDDs) and identified three significantly enriched missense DNM hotspots in the ion transport protein domain family (PF00520). The 37 unique missense DNMs that drive enrichment affect 25 genes, 19 of which were previously associated with NDDs. 3D protein structure modelling supports function-altering effects of these mutations. Hotspot genes have a unique expression pattern in tissue, and we used this pattern alongside in silico predictors and population constraint information to identify candidate NDD-associated genes. We also propose a lenient version of our method, which identifies 32 hotspot positions across 16 different protein domains. These positions are enriched for likely pathogenic variation in clinical databases and DNMs in other genetic disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was in part financially supported by grants from the Netherlands Organization for Scientific Research (916-14-043 to C.G. and 918-15-667 to J.A.V.), and from the Radboud Institute for Molecular Life Sciences, Radboud University Medical Center (R0002793 to G.V.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available human data. Developmental disorder (NDD) DNMs: Kaplanis et al., Nature, 2020. Autism-spectrum disorder (ASD) DNMs: Satterstrom et al., Cell, 2020. Congenital heart defect (CHD) DNMs: Jin et al., Nature Genetics, 2017. DNMs from unaffected individuals: Jonsson et al., Nature, 2017; Satterstrom et al., Cell, 2020. All papers are cited in text. Additionally, expression data used for this work is openly available and may be obtained from GTEx v8: https://gtexportal.org/home/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Most data produced in this study are contained in the manuscript. All data produced in this study are available upon reasonable request to the authors.
